On ECHEMI
Home > Drugs > Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
  • Founded in:

    1988-10-08
  • Country:

    China China
  • Address:

    No. 5 Jian'an Street, Beijing Economic and Technological Development Zone, Beijing
  • Tax NO.:

    91110302101942400P
  • Registered Funds:

    350.92759 million yuan
  • Website:

  • Email:

Related Drugs
Recombinant human interleukin-2 injection
Recombinant human interleukin-2. Excipients: sodium acetate, glacial acetic acid, sodium chloride, polysorbate-80.
Name Description Content CAS NO. Registered Holders
Recombinant human interleukin-2

It is a lymphokine that can cause the proliferation of cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the function of promoting the body's immune response.

More

It is a lymphokine that can cause the proliferation of cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the function of promoting the body's immune response.

0
Recombinant human interleukin-2 injection
Main ingredients: recombinant human interleukin-2.
Name Description Content CAS NO. Registered Holders
INTERLEUKIN-2

This product is a lymphokine that can proliferate cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the effect of promoting the body's immune response.

More

This product is a lymphokine that can proliferate cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the effect of promoting the body's immune response.

102524-44-7 0
Recombinant human interleukin-2 injection
Main ingredients: recombinant human interleukin-2.
Name Description Content CAS NO. Registered Holders
INTERLEUKIN-2

This product is a lymphokine that can proliferate cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the effect of promoting the body's immune response.

More

This product is a lymphokine that can proliferate cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the effect of promoting the body's immune response.

102524-44-7 0
Recombinant human interleukin-2 injection
Main ingredients: recombinant human interleukin-2
Name Description Content CAS NO. Registered Holders
INTERLEUKIN-2

This product is a lymphokine that can proliferate cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the effect of promoting the body's immune response.

More

This product is a lymphokine that can proliferate cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also promote lymphocytes to secrete antibodies and interferon, and has the effect of promoting the body's immune response.

102524-44-7 0
Recombinant human erythropoietin injection (CHO cells)
Main ingredients: recombinant streptokinase.
Name Description Content CAS NO. Registered Holders
STREPTOKINASE

Recombinant streptokinase combines with plasminogen in a 1:1 molar ratio to form a complex, which then activates plasminogen into plasmin. Plasmin catalyzes the hydrolysis of fibrin, the main matrix of thrombus, thereby dissolving the thrombus and reopening the blood vessels. At the same time, the thrombolytic effect of recombinant streptokinase is enhanced by the presence of fibrin. Therefore, recombinant streptokinase can effectively and specifically dissolve thrombus or blood clots, and can treat diseases with thrombosis as the main pathological change.

More

Recombinant streptokinase combines with plasminogen in a 1:1 molar ratio to form a complex, which then activates plasminogen into plasmin. Plasmin catalyzes the hydrolysis of fibrin, the main matrix of thrombus, thereby dissolving the thrombus and reopening the blood vessels. At the same time, the thrombolytic effect of recombinant streptokinase is enhanced by the presence of fibrin. Therefore, recombinant streptokinase can effectively and specifically dissolve thrombus or blood clots, and can treat diseases with thrombosis as the main pathological change.

9002-01-1 1
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.